Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03731572 · ClinicalTrials.gov registry record · NA
Hip Muscle Power, Lateral Balance Function, and Falls in Aging
A NA study of Accidental Falls, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 97
- Enrollment target
- 1
- Study location
NCT03731572: Completed NA study of Accidental Falls, sponsored by University of Maryland, Baltimore.
NCT03731572 is a NA study of Accidental Falls that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 97 participants, below the 201-participant average among 12 other Accidental Falls trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03731572, a NA study of Accidental Falls, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 97 participants
- Enrollment target
- 1
- Study location
Study Summary
Falls and their consequences are among the major problems in the medical care of older individuals. The long-term goal of this research is to develop a mechanistically based therapeutic intervention to enhance muscle power, weight-shifting capability, and lateral balance function through protective stepping to prevent falls. When human balance is challenged, protective stepping is a vital strategy for preventing a fall during activities of daily life. Many older people at risk for falls have particular difficulties with successfully stepping sideways as a protective response to loss of balance in the lateral direction. Age-related declines in lateral balance function result from neuromuscular and biomechanical limitations in hip abductor-adductor muscle power generation. This study will test whether these impairments can be improved with high-velocity hip muscle resistance power training that will be more effective than conventional resistance strength training.
Primary Outcome
Change in number of single steps between pre and post tests
Conditions Studied
Interventions
- OTHER Strength Training
- OTHER Power Training
Study Locations (1)
Maryland
- VA Maryland Health Care System - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2019-09-16 |
| Est. Completion | 2026-01-10 |
| Phase | NA |
What the finished NCT03731572 record still lists
NCT03731572 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 97 participants, a relatively small participant target, below the 201-participant average among 12 other Accidental Falls trials with a reported enrollment target (52% lower).
The record links to 1 condition, with Accidental Falls appearing as the primary indexed condition, and to 2 interventions - of which Strength Training is the first listed.
NCT03731572 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT03731572 about?
NCT03731572 is a clinical study titled "Hip Muscle Power, Lateral Balance Function, and Falls in Aging". Falls and their consequences are among the major problems in the medical care of older individuals. The long-term goal of this research is to develop a mechanistically based therapeutic intervention to enhance muscle power, weight-shifting capability, and lateral balance function through protective ...
What is the current status of trial NCT03731572?
This trial is currently completed. It is a NA study. The enrollment target is 97 participants. The study started on 2019-09-16. Estimated completion is 2026-01-10.
What conditions does trial NCT03731572 study?
This clinical trial studies the following conditions: Accidental Falls.
What interventions are being tested in trial NCT03731572?
The interventions under investigation include: Strength Training (OTHER), Power Training (OTHER).
Who is sponsoring clinical trial NCT03731572?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03731572 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Accidental Falls
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03731572's enrollment target sits among peer trials
97 5th of 12 higher than 8 of 12 other Accidental Falls trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Accidental Falls trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Occupational Therapy and Registered Dietitian Services to Reduce Fall Risk Among Home Delivered Meal Clients
RECRUITING · NA
-
A Study of Dual-task Exercise Training to Prevent Falls Among Older Adults With Mild Cognitive Impairment
RECRUITING · NA
-
Feasibility of Home-based tES for Older Adults at Risk of Falling
RECRUITING · NA
-
Use of Tele-Exercise for Translating an Evidence-Based Fall-Prevention Program for Older Adults in West Virginia
COMPLETED · NA
-
Effects of Protective Step Training on Proactive and Reactive Motor Adaptations in Parkinson's Disease Patients
COMPLETED · NA
-
Marketing Fall Prevention Classes to Older Adults in Faith-Based Congregations
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03948490 · 97 participants · NA
Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas
- NCT04140487 · 97 participants · Phase 1
Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
- NCT04196413 · 97 participants · Phase 1
GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)
- NCT05223816 · 97 participants · Phase 2
An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI